Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 24SevenOffice 247 Oct 3, 2022 5.98 +0.67   
 2cureX 2CUREX Oct 3, 2022 9.74 +3.40   
 4C Group AB 4C Oct 3, 2022 36.49 -6.21   
 AAC Clyde Space AAC Oct 3, 2022 1.22 -0.25   
 AAK AAK Oct 3, 2022 146.10 -0.85   
 ABB ABB Oct 3, 2022 270.00 -7.94   
 Abelco Investment Group ABIG Oct 3, 2022 0.07 +15.63   
 Abera Bioscience ABERA Oct 3, 2022 5.00 -0.99   
 ABL Group ABLO Oct 3, 2022 12.50 0.00   
 Abliva ABLI Oct 3, 2022 0.19 +2.77   
 Absolent Air Care Group ABSO Oct 3, 2022 337.00 -4.53   
 Absolicon B ABSLB Oct 3, 2022 101.00 0.00   
 AcadeMedia ACAD Oct 3, 2022 49.26 +1.99   
 Acarix ACARIX Oct 3, 2022 0.67 -1.18   
 Acast ACAST Oct 3, 2022 8.11 +1.06   
 Acconeer ACCON Oct 3, 2022 42.95 +2.02   
 Acosense ACOS Oct 3, 2022 0.31 +17.69   
 AcouSort ACOU Oct 3, 2022 15.56 +0.52   
 ACQ Bure ACQSPAC Oct 3, 2022 91.20 0.00   
 Acrinova A ACRIA Oct 3, 2022 8.66 -5.25   
 Acrinova B ACRIB Oct 3, 2022 7.10 +0.57   
 ACROUD ACROUD Oct 3, 2022 1.82 -0.27   
 Actic Group ATIC Oct 3, 2022 7.30 -2.41   
 Active Biotech ACTI Oct 3, 2022 0.92 -1.51   
 AcuCort ACUC Oct 3, 2022 2.10 +13.51   
 Acuvi AB ACUVI Oct 3, 2022 21.05 -3.66   
 AdderaCare ADDERA Oct 3, 2022 2.68 -2.19   
 AddLife B ALIFB Oct 3, 2022 120.00 +3.18   
 Addnode Group B ANODB Oct 3, 2022 78.95 +1.94   
 Addtech B ADDTB Oct 3, 2022 148.20 +0.54   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+